GlassScriptPhysician profile
David E Kavesteen
NPI 1891719902
$8,710.69
in general payments reported to CMS, 2019-2025
47 companies · $1,412 in 2025
The $1,412 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $566 · 2020: $779 · 2021: $1,087 · 2022: $1,533 · 2023: $2,130 · 2024: $1,203 · 2025: $1,412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,745.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,762.68 | 2019-2025 | Cardiomems, Gallant, Optis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $673.44 | 2019-2023 | Jardiance |
| Medtronic, INC. | $664.82 | 2022-2025 | Onyx Frontier, Linq II, Inceptiv |
| Biotronik INC. | $423.88 | 2019-2021 | |
| Amgen INC. | $381.62 | 2019-2024 | Tepezza, Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $262.75 | 2022-2024 | |
| Boston Scientific Corporation | $261.18 | 2022-2024 | Apollo Esg System, Varithena Administration Pack |
| Cvrx, INC. | $248.08 | 2022-2023 | Barostim Neo System |
| Heartflow, INC. | $235.14 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $231.17 | 2020-2023 | Lifevest |
| Kestra Medical Technology Services, INC. | $199.67 | 2023-2025 | Assure Wcd |
| Novo Nordisk INC | $194.99 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Atricure, INC. | $191.38 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Renalytix Ai, INC. | $188.38 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Amarin Pharma, INC. | $157.25 | 2019-2021 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $138.45 | 2019-2022 | |
| Lilly USA, LLC | $137.48 | 2021-2025 | Zepbound, Mounjaro |
| Optinose US, INC. | $121.53 | 2021 | |
| Abbvie INC. | $110.39 | 2024 | |
| Echosens North America, INC. | $104.17 | 2025 | Fibroscan |
| Astrazeneca Pharmaceuticals LP | $79.36 | 2019-2024 | Farxiga |
| Baxter Healthcare | $78.38 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Edwards Lifesciences Corporation | $72.13 | 2023 | Sapien 3 Ultra Resilia |
| Pfizer INC. | $67.13 | 2021-2025 | |
| Esperion Therapeutics, INC. | $66.61 | 2021-2024 | Nexletol |
| Siemens Medical Solutions USA, INC. | $62.39 | 2023 | Acuson Redwood Diagnostic Ultrasound System |
| Medicomp INC | $57.74 | 2022-2025 | Telepatch Cardiac Monitor |
| Kowa Pharmaceuticals America, INC. | $56.19 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $51.18 | 2024 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $45.78 | 2022-2025 | Dupixent |
| Eisai INC. | $45.35 | 2024-2025 | |
| Itamar Medical INC | $32.05 | 2025 | Watchpatone |
| Glaxosmithkline, LLC. | $31.97 | 2022-2023 | Nucala |
| Medtronic Vascular, INC. | $27.16 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $25.46 | 2024 | Camzyos |
| Kaleo, INC. | $23.22 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $23.08 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $21.49 | 2023 | |
| Zimmer Biomet Holdings, INC. | $21.01 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Lundbeck LLC | $20.53 | 2019 | |
| Phadia US INC. | $20.49 | 2025 | Immunocap |
| Tactile Systems Technology INC | $19.40 | 2024 | Entre Plus, Flexitouch Plus |
| Actelion Pharmaceuticals US, INC. | $17.54 | 2025 | Uptravi, Opsumit |
| Philips North America LLC | $14.90 | 2024 | (5044) Mcot |
| Advanced Oxygen Therapy INC. | $14.48 | 2024 | Topical Oxygen Chamber For Extremities |
| Vistapharm, INC. | $14.29 | 2021 | |
| G Medical Diagnostic Services, INC. | $12.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kavesteen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.